WIM
ALXN

Westside Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Westside Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,459
Closed -$819 – 785
2021
Q2 		$819 Sell
4,459
-4,842
-52% -$831K ﹤0.01% 251
2021
Q1 		$1.42K Hold
9,301
– – ﹤0.01% 227
2020
Q4 		$1.45K Sell
9,301
-110
-1% -$14.1K ﹤0.01% 182
2020
Q3 		$1.08K Buy
9,411
+1,230
+15% +$133K ﹤0.01% 202
2020
Q2 		$918 Buy
8,181
+130
+2% +$13.8K ﹤0.01% 184
2020
Q1 		$722 Buy
+8,051
New +$790K ﹤0.01% 192
2019
Q2 		$699 Buy
+5,344
New +$689K ﹤0.01% 131
2018
Q4 		$522K Buy
5,365
+770
+17% +$91K 0.19% 89
2018
Q3 		$630K Hold
4,595
– – 0.2% 77
2018
Q2 		$574K Buy
4,595
+230
+5% +$26.9K 0.2% 79
2018
Q1 		$474K Buy
4,365
+640
+17% +$76.5K 0.26% 85
2017
Q4 		$446K Hold
3,725
– – 0.24% 92
2017
Q3 		$526K Hold
3,725
– – 0.32% 74
2017
Q2 		$461K Buy
3,725
+2,975
+397% +$346K 0.3% 79
2017
Q1 		$87.2K Buy
+750
New +$96.7K 0.04% 203

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Westside Investment Management's ALXN Position: Q3 2021 in Review

Westside Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,459 shares — an estimated $819 sold.

Westside Investment Management first reported a position in ALXN in Q1 2017 and held it in 15 quarters. The position peaked at $630K in Q3 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Westside Investment Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Westside Investment Management sold 4,459 Alexion Pharmaceuticals shares in Q3 2021, an estimated $819.
  • Westside Investment Management first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 15 quarters.
  • Westside Investment Management's Alexion Pharmaceuticals position peaked at $630K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Westside Investment Management's 13F filing for Q3 2021, filed 27 Oct 2021.